All In Biotech

Guides

How to find every clinical trial for a drug on ClinicalTrials.gov

How to find clinical trials for a drug on ClinicalTrials.gov: search by intervention, add code names, filter by phase and status, and check other registries.

By the All In Biotech editorial team · Published November 18, 2026 · 6 min read

To find every clinical trial for a drug, search ClinicalTrials.gov using the Intervention/treatment field with the drug's generic name, then repeat with the brand name and the company's development code, and set the status filter to include all statuses. Combine the results by NCT number to remove duplicates. For trials run outside the US, also check the WHO and EU registries.

What ClinicalTrials.gov covers

ClinicalTrials.gov is run by the National Library of Medicine at the National Institutes of Health. It went live in 2000. It covers studies of drugs, biologics, devices, behavioral interventions and observational research, from sponsors around the world.

Registration became a legal requirement for many trials under section 801 of the Food and Drug Administration Amendments Act of 2007 (FDAAA 801). The final rule, codified at 42 CFR Part 11 and in effect since January 18, 2017, sets out:

  • Which trials must register: "applicable clinical trials", which for drugs means controlled clinical investigations other than phase 1 trials, with a link to the US such as a US site or an FDA application.
  • When: no later than 21 days after the first participant is enrolled.
  • Results: summary results, generally due within one year of the primary completion date.

Because phase 1 trials and many non-US trials fall outside the law, coverage is good but not complete. Medical journals also require registration before publication, which brings in many trials the law does not cover.

Step by step: searching for a drug

1. Use the intervention field

The general search box on ClinicalTrials.gov matches words anywhere in a record, including eligibility criteria. A search for a drug name there will return trials where the drug is only mentioned, for example as a prior treatment patients must have had. The Intervention/treatment field limits matches to the drugs being studied.

2. Search every name the drug has had

A drug is often registered under different names at different stages:

  • Generic name, such as pembrolizumab.
  • Brand name, such as Keytruda.
  • Development code, the company's code before a generic name was assigned. Pembrolizumab was MK-3475.

ClinicalTrials.gov expands some searches to known synonyms, but early trials registered under a code name are easy to miss. The drug's FDA label lists the generic name, and company pipeline pages or press releases usually give the development code.

3. Widen the status filter

Searches are often filtered to recruiting studies by default or by habit. To see a drug's full history, include all statuses:

StatusMeaning
Not yet recruitingRegistered, not yet enrolling
RecruitingCurrently enrolling
Active, not recruitingEnrollment closed, participants still being followed
CompletedEnded normally
TerminatedStopped early; the record often gives a reason
WithdrawnStopped before enrolling anyone
SuspendedPaused, may restart
UnknownNot verified by the sponsor in the past two years

Terminated and withdrawn trials matter for research: they can show safety problems, slow enrollment or business decisions.

4. Narrow by phase, sponsor and condition

Once you have the full set, filter as needed:

  • Phase: phase 3 trials are usually the ones that support approval. Phase 4 trials are run after approval.
  • Study type: interventional trials test a treatment; observational studies follow patients without assigning treatment.
  • Sponsor: separates company-sponsored studies from academic and NIH-funded ones.
  • Condition: shows which diseases a drug is being tested in, which is often the clearest picture of a drug's development plan.
  • Results: limits the list to trials with posted results.

5. Read the record

Each study record shows the NCT number, sponsor, design, arms, primary and secondary outcome measures, enrollment, dates, locations and, where posted, results. The record history tab shows every change to the record over time, including changes to the primary outcome, which can be relevant when comparing published results with the original plan.

6. Export or use the API

Search results can be downloaded, and ClinicalTrials.gov offers a free data API for larger pulls. This is how tools that track pipelines across many drugs get their data.

Doing the same search on this site

This site's trials tool queries ClinicalTrials.gov directly and focuses on drug and biologic studies. Filters are saved in the page address, so a view can be bookmarked or shared. It filters by therapeutic area, phase, sponsor type, sponsor name, status, enrollment, start date and distance from a US ZIP code.

Two defaults to know: the tool starts with recruiting trials and industry sponsors. To see a drug's full trial history, set the status to any status and the sponsor type to all sponsors, for example all pembrolizumab trials.

For scale: as of November 2026, this site's data count 2,877 registered trials on ClinicalTrials.gov naming pembrolizumab. Each drug page on the site, such as Keytruda's, links to its trials alongside its approval history and FAERS data.

Searching by condition instead of drug

Sometimes the question is not "what trials does this drug have" but "what is being tested for this disease". In that case, put the disease in the Condition/disease field and leave the intervention blank. ClinicalTrials.gov maps many conditions to standard medical vocabulary, so a search for a broad term can also return closely related terms.

Two habits make condition searches more useful:

  • Limit the study type to interventional and the phase to 2 or 3 to focus on treatments in mid- and late-stage testing.
  • Sort by start date to see which programs are newest.

To compare those trials with drugs already approved for the same disease, the site's condition pages list approved treatments, for example type 2 diabetes and non-small cell lung cancer. The condition search guide explains how those lists are built.

Other registries to check

ClinicalTrials.gov is not the only registry. For trials run mainly outside the US:

  • WHO International Clinical Trials Registry Platform (ICTRP): a search portal that combines records from national and regional registries, including ClinicalTrials.gov, the EU registry, China, Japan, India and others.
  • EU Clinical Trials Information System (CTIS): the EU registry for trials authorized under the EU Clinical Trials Regulation.

The same trial can appear in several registries with different identifiers. Records often list secondary IDs, which helps match them.

Common pitfalls

  • Counting duplicates. Searches for the generic name, brand name and code name overlap heavily. Deduplicate by NCT number.
  • Combination trials. Many trials test a drug with others. A search for one drug returns every combination it appears in, which can overstate how much a company itself is running.
  • Investigator-sponsored studies. Academic investigators often study approved drugs without the manufacturer as sponsor. Filter by sponsor if you want only company trials.
  • Stale status. Sponsors update records, but not always promptly. Check the last update date, and treat "unknown" status records with caution.
  • Missing results. Absence of posted results does not mean a trial failed. Results may be in a journal, in FDA review documents, or overdue.

Where trials fit with other data

Trials show what is being tested; FDA records show what was approved. For an approved drug, FDA's review documents in Drugs@FDA describe the trials that supported approval; see how to search Drugs@FDA. For companies, trial lists combined with upcoming FDA action dates give a picture of a pipeline, as described in how to research a biotech pipeline with free data.

Frequently asked questions

How do I search ClinicalTrials.gov for a specific drug?
Put the drug's generic name in the Intervention/treatment field rather than the general search box, then repeat the search with its brand name and development code. Set the status filter to all statuses to include completed and terminated trials.
What is an NCT number?
It is the unique identifier ClinicalTrials.gov assigns to each registered study, written as NCT followed by eight digits. It stays the same for the life of the study and is the most reliable way to cite or look up a trial.
Are all clinical trials on ClinicalTrials.gov?
No. US law requires registration of most controlled trials of FDA-regulated drugs, but phase 1 trials are exempt from that requirement and some trials run only outside the US are listed in other registries instead.
Does ClinicalTrials.gov have trial results?
Many trials covered by US law must post summary results, generally within one year of the primary completion date, but results are missing for many older and exempt studies.

For information only, not medical, legal or investment advice. Facts about FDA and CMS programs are current as of the publication date; check the linked official source for changes.

Keep reading